Reduced Oxidative Phosphorylation and Increased Glycolysis in Human Glaucoma Lamina Cribrosa Cells

Invest Ophthalmol Vis Sci. 2020 Nov 2;61(13):4. doi: 10.1167/iovs.61.13.4.

Abstract

Purpose: The lamina cribrosa (LC) is a key site of damage in glaucomatous optic neuropathy. We previously found that glaucoma LC cells have an increased profibrotic gene expression, with mitochondrial dysfunction in the form of decreased mitochondrial membrane potential. Altered cell bioenergetics have recently been reported in organ fibrosis and in cancer. In this study, we carried out a systematic mitochondrial bioenergetic assessment and measured markers of alternative sources of cellular energy in normal and glaucoma LC cells.

Methods: LC cells from three glaucoma donors and three age-matched normal controls were assessed using VICTOR X4 Perkin Elmer (Waltham, MA) plate reader with different phosphorescent and luminescent probes. adenosine triphosphate levels, oxygen consumption rate, and extracellular acidification were measured and normalized to total protein content. RNA and protein expression levels of MCT1, MCT4, MTFHD2, and GLS2 were quantified using real-time RT-PCR and Western blotting.

Results: Glaucoma LC cells contain significantly less adenosine triphosphate (P < .05) when supplied with either glucose or galactose. They also showed significantly diminished oxygen consumption in both basal and maximal respiration with more lactic acid contribution in ECA. Both mRNA and protein expression levels of MCT1, MCT4, MTHFD2, and GLS2 were significantly increased in glaucoma LC cells.

Conclusions: We demonstrate evidence of metabolic reprogramming (The Warburg effect) in glaucoma LC cells. Expression of markers of glycolysis, glutamine, and one carbon metabolism are elevated in glaucoma cells at both the mRNA and protein levels. A better understanding of bioenergetics in glaucoma may help in the development of new therapeutics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Aminohydrolases / genetics
  • Aminohydrolases / metabolism
  • Biomarkers
  • Blotting, Western
  • Cells, Cultured
  • Gene Expression Profiling
  • Glaucoma, Open-Angle / metabolism*
  • Glaucoma, Open-Angle / pathology
  • Glial Fibrillary Acidic Protein / metabolism
  • Glutaminase / genetics
  • Glutaminase / metabolism
  • Glycolysis / physiology*
  • Humans
  • Methylenetetrahydrofolate Dehydrogenase (NADP) / genetics
  • Methylenetetrahydrofolate Dehydrogenase (NADP) / metabolism
  • Mitochondrial Diseases / metabolism*
  • Mitochondrial Diseases / pathology
  • Monocarboxylic Acid Transporters / genetics
  • Monocarboxylic Acid Transporters / metabolism
  • Multifunctional Enzymes / genetics
  • Multifunctional Enzymes / metabolism
  • Muscle Proteins / genetics
  • Muscle Proteins / metabolism
  • Optic Disk / metabolism*
  • Optic Disk / pathology
  • Optic Nerve Diseases / metabolism*
  • Optic Nerve Diseases / pathology
  • Oxidative Phosphorylation*
  • Oxygen Consumption / physiology
  • RNA, Messenger / genetics
  • Real-Time Polymerase Chain Reaction
  • Symporters / genetics
  • Symporters / metabolism
  • Tissue Donors

Substances

  • Biomarkers
  • GFAP protein, human
  • Glial Fibrillary Acidic Protein
  • MTHFD2 protein, human
  • Monocarboxylic Acid Transporters
  • Multifunctional Enzymes
  • Muscle Proteins
  • RNA, Messenger
  • SLC16A4 protein, human
  • Symporters
  • monocarboxylate transport protein 1
  • Adenosine Triphosphate
  • Methylenetetrahydrofolate Dehydrogenase (NADP)
  • GLS2 protein, human
  • Glutaminase
  • Aminohydrolases